VOXZOGO (vosoritide) for injection
VOXZOGO is a C type natriuretic peptide (CNP) analog indicated to increase linear growth in pediatric patients with achondroplasia with open epiphyses. FDA approved vosoritide (brand name VOXZOGO) is not (yet) registered or available in India. The access to the drug is provided as per Name Patient Program respecting the regulatory framework as desired by local authorities.
Home | vosoritide injection
Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!
For Indian Patient Enquiry under NPP.
For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.
VOXZOGO (vosoritide) for injection
Vosoritide, is a medication used for the treatment of achondroplasia, a genetic condition that causes severely short stature and disproportionate growth.
VOXZOGO is a C type natriuretic peptide (CNP) analog indicated to increase linear growth in pediatric patients with achondroplasia with open epiphyses. Active ingredient: vosoritide. Inactive ingredients: trehalose dihydrate, mannitol, sodium citrate dihydrate, methionine, citric acid monohydrate, and polysorbate 80
Vosoritide, sold under the brand name Voxzogo, is a medication used for the treatment of achondroplasia, a genetic condition that causes severely short stature and disproportionate growth.
Achondroplasia is caused by a genetic mutation that increases the activity of a certain growth regulation gene called fibroblast growth factor receptor 3 (FGFR3). The overabundance of protein coded by the FGFR3 gene prevents normal bone growth.
In the European Union, vosoritide is indicated for the treatment of achondroplasia in people two years of age and older whose epiphyses are not closed. In the United States, vosoritide is indicated to increase growth in children five years of age and older with achondroplasia and open epiphyses (growth plates).
The most common side effects include injection site reactions (such as swelling, redness, itching, or pain), vomiting, and decreased blood pressure.
Drug (Brand / Generic): VOXZOGO (vosoritide) for injection, for subcutaneous use Initial U.S. Approval: 2021
Current Indication: To increase linear growth in pediatric patients with achondroplasia with open epiphyses.
Approval Date: 2021
For injection: 0.4 mg, 0.56 mg, or 1.2 mg of vosoritide as a lyophilized powder in a single-dose vial for reconstitution
Find Reference Updates
- VOXZOGO (vosoritide) for injection Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions.
- FDA Approves First Drug to Improve Growth in Children with Most Common Form of Dwarfism
- Vosoritide, a miracle drug, covering unmet need in achondroplasia: A regulatory update
- U.S. Food and Drug Administration Approves BioMarin's VOXZOGO® (vosoritide) for Children Under 5 Years with Achondroplasia
For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here
Alleviare Life Sciences
About Us
Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.
Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.
Alleviare India is a trusted pharmaceutical access facilitator in India, aligned with Good Distribution Practice (GDP) standards. We provide specialized support to help patients and healthcare professionals access VOXZOGO (vosoritide) for injection, an internationally approved therapy.
Where VOXZOGO is not commercially available in India, we facilitate access through regulated pathways such as the Named Patient Supply (NPS) framework. Each request is carefully managed in compliance with applicable regulations and requires a valid prescription and, where necessary, import authorization.
Get Access to FDA approved vosoritide (brand name VOXZOGO) in India.
We can help patients access approved VOXZOGO (vosoritide) for injection in the following cities across India – Ahmedabad, Bangalore, Surat, Kolkata, Pune, Indore, Nagpur, Agra, Kanpur, Patna, Coimbatore, Kochi, Delhi, Gurugram, Amaravati, Itanagar, Dispur, Patna, Raipur, Panaji, Gandhinagar, Chandigarh, Shimla, Ranchi, Bengaluru, Thiruvananthapuram, Bhopal, Mumbai, Imphal, Shillong, Aizawl, Kohima, Bhubaneswar, Jaipur, Gangtok, Chennai, Hyderabad, Agartala, Lucknow, Dehradun, Gairsain. Aizawal, Aurangabad, Barshi, Cachar, Dibrugarh, Karungapally, Kollam, Meghalaya, Mizoram, Sikkim, Pondichery, Punjab, Tripura, New Delhi, Agra, Gurugram, Alwar, Mathura, Panipat, Faridabad, Noida, Sonipat, Rohtak, Karnal, Ambala, Ghaziabad.VOXZOGO (vosoritide) for injection – Sourcing & Access Support
Alleviare India provides assistance in facilitating access to VOXZOGO (vosoritide) for injection, a prescribed oncology medication, through trusted international supply channels. We support patients and healthcare providers in identifying appropriate supply options for medicines that may have limited local availability, in accordance with applicable regulations.Access is provided only against a valid prescription, and services are offered under the Named Patient Supply (NPS) framework. Alleviare India may also assist in connecting with authorized supply channels where appropriate.Pricing & Availability in India
For information on the availability and indicative pricing of VOXZOGO (vosoritide) for injection, please contact us directly.The cost of the medicine is determined by the manufacturer. Additional charges may include Named Patient support service fees, shipping costs, and applicable local taxes, in accordance with regulatory requirements.Is VOXZOGO available in India?
Meet Our Medicine Access Expert for availability of Truqap medications.At Alleviare, we prioritize transparency while supporting patients, healthcare professionals, and institutions in accessing genuine medicines through trusted global sources in Canada, Europe, the USA, and Australia. We provide tailored assistance to facilitate access to prescribed therapies, including those not readily available locally, in full compliance with applicable regulatory requirements.Access is facilitated under the Named Patient Supply (NPS) framework. We also offer guidance on the availability and indicative pricing of prescribed medications across major cities in India, including Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, and Pune.Medicine: VOXZOGO (vosoritide) for injection (subject to prescription and regulatory guidelines)Start Your Access JourneyEmail: info@alleviareindia.com, Mobile: +91 9818274099 / 9289711088Is vosoritide available in India?Yes, FDA approved vosoritide (brand name VOXZOGO) is not (yet) registered or available in India but on request Indian patient can buy VOXZOGO at the lowest price.What documents are required to import VOXZOGO to India?
To import VOXZOGO (vosoritide), patients or government hospitals can place an order on behalf of the patients. The following documentation is required for the import process:- Valid prescription from a qualified doctor.
- Patients’ diagnostic reports.
- Patients’ ID proof issued by the Government of India.
- Valid prescription from the doctor.
- Import permit, if applicable.